create a website

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. (2007). Molken, Maureen Rutten-Van ; Miravitlles, Marc ; Oostenbrink, Jan ; Monz, Brigitta .
In: The European Journal of Health Economics.
RePEc:spr:eujhec:v:8:y:2007:i:2:p:123-135.

Full description at Econpapers || Download paper

Cited: 5

Citations received by this document

Cites: 39

References cited by this document

Cocites: 45

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease. (2012). Leidl, Reiner ; Holle, Rolf ; Menn, Petra .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:30:y:2012:i:9:p:825-840.

    Full description at Econpapers || Download paper

  2. Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease. (2012). Molken, Maureen Rutten-Van ; Goossens, Lucas .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:30:y:2012:i:4:p:271-302.

    Full description at Econpapers || Download paper

  3. New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses. (2012). Roberts, Melissa ; Mapel, Douglas .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:30:y:2012:i:10:p:869-885.

    Full description at Econpapers || Download paper

  4. Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy. (2012). Iannazzo, S. ; Zaniolo, O. ; Miravitlles, M. ; Pradelli, L..
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:13:y:2012:i:1:p:71-80.

    Full description at Econpapers || Download paper

  5. Comparing Methods of Data Synthesis. (2011). Rutten-Molken, Maureen ; Oppe, Mark ; Al, Maiwenn.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:29:y:2011:i:3:p:239-250.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Anzueto, A., Tashkin, D., Menjoge, S., Kesten, S.: One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium, Pulm. Pharmacol. Ther. 18(2), 75–81 (2005).
    Paper not yet in RePEc: Add citation now
  2. Ayres, J.G., Price, M.J., Efthimiou, J.: Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial. Respir. Med. 97(3), 212–220 (2003).
    Paper not yet in RePEc: Add citation now

  3. Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med. Decis. Making 21(1), 7–16 (2001).

  4. Barnes, P.J.: Chronic obstructive pulmonary disease: new treatments for COPD. Thorax 58(9), 803–808 (2003).
    Paper not yet in RePEc: Add citation now
  5. Briggs, A.: Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health 8(1):1–2 (2005).
    Paper not yet in RePEc: Add citation now

  6. Briggs, A.H., Fenn, P.A.: Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ. 7, 723–740 (1998).

  7. Briggs, A.H., Sculpher, M.: An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13(4), 397–409 (1998).
    Paper not yet in RePEc: Add citation now
  8. Briggs, A.H.: Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 17(5), 479–500 (2000).
    Paper not yet in RePEc: Add citation now
  9. Brusasco, V., Hodder, R., Miravitlles, M., et al.: Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58(5), 399–404 (2003).
    Paper not yet in RePEc: Add citation now
  10. Casaburi, R., Mahler, D.A., Jones, P.W., Wanner, A., San, P.G., ZuWallack, R.L., Menjoge, S.S., Serby, C.W., Witek, T.J., Jr.: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 19(2), 217–224 (2002).
    Paper not yet in RePEc: Add citation now
  11. Chapman, R.H., Stone, P.W., Sandberg, E.A., Bell, C., Neumann, P.J.: A comprehensive league table of cost-utility ratios and a sub-table of “panel-worthy” studies. Med. Decis. Making 20(4), 451–67 (2000).
    Paper not yet in RePEc: Add citation now
  12. Decramer, M., Celli, B.R., Tashkin, D.P., Pauwels, R.A., Burkhart, D., Cassino, C., Kesten, S.: Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the Uplift trial. J. Chron. Obstruct. Pulm. Dis. 1(2), 303–312 (2004).
    Paper not yet in RePEc: Add citation now
  13. Donaldson, G.C., Seemungal, T.A., Bhowmik, A., Wedzicha, J.A.: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10), 847–852 (2002).
    Paper not yet in RePEc: Add citation now
  14. Esteban, C., Moraza, J., Aburto, M., Quintana, J.M., Capelastegui, A.: Description of a sample of patients with chronic obstructive pulmonary disease treated at hospital-supervised respiratory clinics at primary care centers. Arch. Bronconeumol. 39(11), 485–490 (2003).
    Paper not yet in RePEc: Add citation now

  15. Fenwick, E., Claxton, K., Sculpher, M.: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 10(8), 779–787 (2001).

  16. Gallefoss, F., Bakke, P.S.: Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD—a 1-year follow-up randomized, controlled trial. Respir. Med. 96(6), 424–431 (2002).
    Paper not yet in RePEc: Add citation now
  17. Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C.: Cost-effectiveness in Health and Medicine, 1st edn. Oxford University Press, New York (1996).
    Paper not yet in RePEc: Add citation now
  18. Hjelmgren, J., Berggren, F., Andersson, F.: Health economic guidelines—similarities, differences and some implications. Value Health 4(3), 225–50 (2001).
    Paper not yet in RePEc: Add citation now
  19. Hogan, T.J., Geddes, R., Gonzalez, E.R.: An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease. Clin. Ther. 25(1), 285–297 (2003).
    Paper not yet in RePEc: Add citation now
  20. Institute for Medical Statistics (IMS) Health: El Marcado Farmaceutico Spain. http://www.imsportal.com (restricted access). Accessed July 2005.
    Paper not yet in RePEc: Add citation now
  21. Jones, P.W., Wilson, K., Sondhi, S.: Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation. Respir. Med. 97(1), 20–26 (2003).
    Paper not yet in RePEc: Add citation now
  22. Kanner, R.E., Anthonisen, N.R., Connett, J.E.: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am. J. Respir. Crit. Care Med. 164(3), 358–364 (2001).
    Paper not yet in RePEc: Add citation now
  23. Langley, P.C.: The NICE reference case requirement: implications for drug manufacturers and health systems. Pharmacoeconomics 22(4), 267–271 (2004).
    Paper not yet in RePEc: Add citation now
  24. Laupacis, A., Feeny, D., Detsky, A.S., Tugwell, P.X.: How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can. Med. Assoc. J. 146(4), 473–481 (1992).
    Paper not yet in RePEc: Add citation now
  25. Miravitlles, M., Ferrer, M., Pont, A., Zalacain, R., Alvarez-Sala, J.L., Masa, F., Verea, H., Murio, C., Ros, F., Vidal, R.: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 59(5), 387–395 (2004).
    Paper not yet in RePEc: Add citation now
  26. Miravitlles, M., Murio, C., Guerrero, T., Gisbert, R.: Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 123(3), 784–791 (2003).
    Paper not yet in RePEc: Add citation now
  27. Miravitlles, M., Murio, C., Guerrero, T., Gisbert, R.: Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121(5), 1449–1455 (2002).
    Paper not yet in RePEc: Add citation now
  28. Miravitlles, M., Murio, C., Guerrero, T.: Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. Eur. Respir. J. 17(5), 928–933 (2001).
    Paper not yet in RePEc: Add citation now
  29. Oostenbrink, J.B., Rutten-van Mölken, M.P.M.H., Monz, B.U., FitzGerald, J.M.: Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. Value Health 8(1), 32–46 (2005).
    Paper not yet in RePEc: Add citation now
  30. Paterson, C., Langan, C.E., McKaig, G.A., Anderson, P.M., Maclaine, G.D., Rose, L.B., Walker, S.J., Campbell, M.J.: Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Qual. Life Res. 9(5), 521–527 (2000).
    Paper not yet in RePEc: Add citation now
  31. Richter, A., Anton, S.E., Koch, P., Dennett, S.L.: The impact of reducing dose frequency on health outcomes. Clin. Ther. 25(8), 2307–2335 (2003).
    Paper not yet in RePEc: Add citation now
  32. Rovira, J., Antonanzas, F.: Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation. Pharmacoeconomics 8(3), 245–252 (1995).
    Paper not yet in RePEc: Add citation now
  33. Rutten-van Mölken, M.P.M.H., van Doorslaer, E.K.A., Jansen, M.C.C., Kerstjens, H.A.M., Rutten, F.F.H.: Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151, 975–982 (1995).
    Paper not yet in RePEc: Add citation now
  34. Sacristan, J.A., Oliva, J., Del Llano, J., Prieto, L., Pinto, J.L.: What is an efficient health technology in Spain? (in Spanish). Gac. Sanit. 16(4), 334–343 (2002).
    Paper not yet in RePEc: Add citation now
  35. Scanlon, P.D., Connett, J.E., Waller, L.A., Altose, M.D., Bailey, W.C., Buist, A.S.: Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 161, 381–390 (2000).
    Paper not yet in RePEc: Add citation now
  36. Sculpher, M.J., Buxton, M.J.: The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics 4(5), 345–352 (1993).
    Paper not yet in RePEc: Add citation now
  37. Spencer, S., Jones, P.W.: Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 58(7), 589–593 (2003).
    Paper not yet in RePEc: Add citation now
  38. Torrance, G., Walker, V., Grossman, R., Mukherjee, J., Vaughan, D., La Forge, J., Lampron, N.: Economic evaluation of Ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. PharmacoEconomics 16 (5 pt1), 499–520 (1999).
    Paper not yet in RePEc: Add citation now
  39. Vincken, W., van Noord, J.A., Greefhorst, A.P., Bantje, T.A., Kesten, S., Korducki, L., Cornelissen, P.J.: Improved health outcomes in patients with COPD during 1 year’s treatment with tiotropium. Eur. Respir. J. 19(2), 209–216 (2002).
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Valuation of the EQ-5D-3L in Jordan. (2025). Rabayah, Abeer ; Roudijk, Bram ; Purba, Fredrick Dermawan ; Rencz, Fanni ; Jaddoua, Saad ; Siebert, Uwe.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:26:y:2025:i:3:d:10.1007_s10198-024-01712-z.

    Full description at Econpapers || Download paper

  2. Comparison of Caregiver and General Population Preferences for Dependency-Related Health States. (2025). Sampayo, Antonio ; Rodrguez-Mguez, Eva.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:23:y:2025:i:1:d:10.1007_s40258-024-00908-x.

    Full description at Econpapers || Download paper

  3. The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia. (2023). Lorgelly, Paula ; Lancsar, Emily ; Ratcliffe, Julie ; Street, Deborah ; Mulhern, Brendan ; Viney, Rosalie ; Norman, Richard.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01243-0.

    Full description at Econpapers || Download paper

  4. Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries. (2022). Janssen, Mathieu F ; Buchholz, Ines ; Bonsel, Gouke J ; Golicki, Dominik.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:40:y:2022:i:11:d:10.1007_s40273-022-01172-4.

    Full description at Econpapers || Download paper

  5. Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer). (2022). Saloniki, Eirini-Christina ; Linnosmaa, Ismo ; Lu, Hui ; Jokimaki, Hanna ; Trukeschitz, Birgit ; Burge, Peter ; Nguyen, Lien ; Batchelder, Laurie ; Malley, Juliette ; Forder, Julien.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:23:y:2022:i:3:d:10.1007_s10198-021-01356-3.

    Full description at Econpapers || Download paper

  6. Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer). (2022). Saloniki, Eirini-Christina ; Burge, Peter ; Nguyen, Lien ; Batchelder, Laurie ; Malley, Juliette ; Forder, Julien ; Linnosmaa, Ismo ; Lu, Hui ; Jokimaki, Hanna ; Trukeschitz, Birgit.
    In: LSE Research Online Documents on Economics.
    RePEc:ehl:lserod:111885.

    Full description at Econpapers || Download paper

  7. General population normative data for the EQ-5D-3L in the five largest European economies. (2021). Pickard, Simon A ; Janssen, Mathieu F ; Shaw, James W.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:22:y:2021:i:9:d:10.1007_s10198-021-01326-9.

    Full description at Econpapers || Download paper

  8. Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates. (2021). Beyh, Yara ; Kharroubi, Samer A.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:22:y:2021:i:5:d:10.1007_s10198-021-01289-x.

    Full description at Econpapers || Download paper

  9. Health-Related Quality of Life Norm Data of the Peruvian Adolescents: Results Using the EQ-5D-Y. (2021). Barrios-Fernandez, Sabina ; Palacios-Cartagena, Roxana Paola ; Hernandez-Mocholi, Miguel Angel ; Garcia-Gordillo, Miguel Angel ; Mendoza-Muoz, Maria ; Adsuar, Jose Carmelo ; Carlos-Vivas, Jorge.
    In: IJERPH.
    RePEc:gam:jijerp:v:18:y:2021:i:16:p:8735-:d:617182.

    Full description at Econpapers || Download paper

  10. Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off. (2021). Oluboyede, Yemi ; Ernu, Simona ; Caplescu, Raluca ; Paveliu, Marian Sorin ; Vale, Luke ; Niculescu-Aron, Ileana-Gabriela ; Olariu, Elena.
    In: IJERPH.
    RePEc:gam:jijerp:v:18:y:2021:i:14:p:7415-:d:592395.

    Full description at Econpapers || Download paper

  11. Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population. (2020). Beyh, Yara ; Kharroubi, Samer A ; el Harake, Marwa Diab ; Brazier, John ; Rowen, Donna ; Dawoud, Dalia.
    In: IJERPH.
    RePEc:gam:jijerp:v:17:y:2020:i:3:p:1037-:d:317371.

    Full description at Econpapers || Download paper

  12. Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Barry, Luke ; Doherty, Edel ; Kelleher, Dan ; Hobbins, Anna.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

    Full description at Econpapers || Download paper

  13. Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries. (2019). Khan, Munir A ; Richardson, Jeff.
    In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement.
    RePEc:spr:soinre:v:145:y:2019:i:1:d:10.1007_s11205-019-02094-z.

    Full description at Econpapers || Download paper

  14. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. (2019). Luo, Nan ; Piercy, James ; Jackson, James ; Yang, Fan ; Moon, Rebecca.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:20:y:2019:i:8:d:10.1007_s10198-019-01088-5.

    Full description at Econpapers || Download paper

  15. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?. (2019). Kharroubi, Samer A ; Rowen, Donna.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-0991-1.

    Full description at Econpapers || Download paper

  16. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. (2019). Hermann, Zoltan ; Brodszky, Valentin ; Baji, Petra ; Pentek, Marta ; Gulacsi, Laszlo ; Rencz, Fanni ; Golicki, Dominik ; Beretzky, Zsuzsanna ; Zrubka, Zsombor ; Prevolnik-Rupel, Valentina.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01069-8.

    Full description at Econpapers || Download paper

  17. Reducing preference reversals: The role of preference imprecision and nontransparent methods. (2018). Sanchez Martinez, Fernando Ignacio ; pinto-prades, jose-luis ; ABELLAN-PERPIÑAN, JOSE-MARIA ; Abellanperpian, Jose Maria ; Pintoprades, Jose Luis ; Martinezperez, Jorge E ; Sanchezmartinez, Fernando Ignacio.
    In: Health Economics.
    RePEc:wly:hlthec:v:27:y:2018:i:8:p:1230-1246.

    Full description at Econpapers || Download paper

  18. Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis. (2016). Viney, Rosalie ; Hole, Arne ; Norman, Richard.
    In: Health Economics.
    RePEc:wly:hlthec:v:25:y:2016:i:2:p:212-224.

    Full description at Econpapers || Download paper

  19. The DEP-6D, a new preference-based measure to assess health states of dependency. (2016). Sampayo, Antonio ; ABELLAN-PERPIÑAN, JOSE-MARIA ; Gonzalez, X M ; Alvarez, X C ; Abellan-Perpian, J M ; Rodriguez-Miguez, E.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:153:y:2016:i:c:p:210-219.

    Full description at Econpapers || Download paper

  20. Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese. (2015). Wang, P ; Luo, N ; Li, M ; Thumboo, J ; Liu, G.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:16:y:2015:i:8:p:857-863.

    Full description at Econpapers || Download paper

  21. Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?. (2015). Perampaladas, Kuhan ; Gaebel, Kathryn ; Xie, Feng ; Pullenayegum, Eleanor ; Doble, Brett.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:16:y:2015:i:8:p:847-855.

    Full description at Econpapers || Download paper

  22. Development of a new preference-based instrument to measure dependency. (2013). Sampayo, Antonio ; Rodríguez Míguez, Eva ; ABELLAN-PERPIÑAN, JOSE-MARIA ; Jose Maria Abellan Perpiñan, ; Jose Manuel Gonzalez Martinez, ; Jose Carlos alvarez Villamarin, ; Miguez, Eva Rodriguez .
    In: Working Papers.
    RePEc:vig:wpaper:1301.

    Full description at Econpapers || Download paper

  23. The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries. (2013). Oppong, Raymond ; Hood, Kerenza ; Coast, Joanna ; Nuttall, Jacqueline ; Kaambwa, Billingsley ; Smith, Richard.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:2:p:197-209.

    Full description at Econpapers || Download paper

  24. Body weight and health-related quality of life in Catalonia, Spain. (2013). oliva, juan ; Oliva-Moreno, Juan ; Gil-Lacruz, Ana.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:1:p:95-105.

    Full description at Econpapers || Download paper

  25. Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states. (2013). Herdman, Michael ; Errea, Maria ; Ramos-Goi, Juan ; Cabases, Juan ; Stolk, Elly ; Rivero-Arias, Oliver.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:1:p:33-42.

    Full description at Econpapers || Download paper

  26. Quality of life lost due to non‐fatal road traffic injuries. (2012). Herrero, Carmen ; Cubi-Molla, Patricia ; CubiMolla, Patricia .
    In: Health Economics.
    RePEc:wly:hlthec:v:21:y:2012:i:5:p:528-550.

    Full description at Econpapers || Download paper

  27. LOWERING THE ‘FLOOR’ OF THE SF‐6D SCORING ALGORITHM USING A LOTTERY EQUIVALENT METHOD. (2012). Sanchez Martinez, Fernando Ignacio ; Jose Maria Abellan Perpiñan, ; Jorge Eduardo Martinez Perez, ; Mendez, Ildefonso ; Sanchezmartinez, Fernando Ignacio.
    In: Health Economics.
    RePEc:wly:hlthec:v:21:y:2012:i:11:p:1271-1285.

    Full description at Econpapers || Download paper

  28. Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China. (2012). Liu, Pei ; Tian, Lin ; Chao, Jianqian ; Jin, Hui ; Wang, Bei ; Gao, Qian.
    In: PLOS ONE.
    RePEc:plo:pone00:0041550.

    Full description at Econpapers || Download paper

  29. Whiners and deniers – What does self-rated health measure?. (2012). Asada, Yukiko ; Kephart, George ; Layes, Audrey .
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:75:y:2012:i:1:p:1-9.

    Full description at Econpapers || Download paper

  30. Inverse probability weighted estimation of social tariffs: An illustration using the SF-6D value sets. (2011). Sanchez Martinez, Fernando Ignacio ; Mendez, Ildefonso ; ABELLAN-PERPIÑAN, JOSE-MARIA ; Sánchez Martínez, Fernando I., ; Martínez Pérez, Jorge E., ; Mndez, Ildefonso ; Abellán Perpiñán, Jose M., .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:30:y:2011:i:6:p:1280-1292.

    Full description at Econpapers || Download paper

  31. A social preference valuations set for EQ-5D health states in Flanders, Belgium. (2010). Cleemput, Irina.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:11:y:2010:i:2:p:205-213.

    Full description at Econpapers || Download paper

  32. Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference?. (2010). Rice, Nigel ; Parkin, David ; Devlin, Nancy.
    In: Medical Decision Making.
    RePEc:sae:medema:v:30:y:2010:i:5:p:556-565.

    Full description at Econpapers || Download paper

  33. Scaling methods for categorical self-assessed health measures. (2010). Cubi-Molla, Patricia ; CubiMolla, Patricia .
    In: Working Papers. Serie AD.
    RePEc:ivi:wpasad:2010-01.

    Full description at Econpapers || Download paper

  34. A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years. (2008). Muir, Kenneth R. ; Barton, Garry R. ; Whynes, David K. ; Jenkinson, Claire ; Avery, Anthony J. ; Sach, Tracey H. ; Doherty, Michael.
    In: Health Economics.
    RePEc:wly:hlthec:v:17:y:2008:i:7:p:815-832.

    Full description at Econpapers || Download paper

  35. Measuring Preferences for Cost-Utility Analysis. (2007). McDonough, Christine ; Tosteson, Anna .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:25:y:2007:i:2:p:93-106.

    Full description at Econpapers || Download paper

  36. Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. (2007). Molken, Maureen Rutten-Van ; Miravitlles, Marc ; Oostenbrink, Jan ; Monz, Brigitta .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:8:y:2007:i:2:p:123-135.

    Full description at Econpapers || Download paper

  37. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method. (2007). Brazier, John ; Kharroubi, S A ; O'Hagan, A.
    In: MPRA Paper.
    RePEc:pra:mprapa:29806.

    Full description at Econpapers || Download paper

  38. Valuing EQ-5D health states: A review and analysis, CHERE Working Paper 2007/9. (2007). Viney, Rosalie ; Norman, Richard ; Brazier, John ; Cronin, Paula ; King, Madeleine ; Ratcliffe, Julie ; Street, Deborah.
    In: Working Papers.
    RePEc:her:chewps:2007/9.

    Full description at Econpapers || Download paper

  39. The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies. (2006). P. F. M. Stalmeier, ; P. F. M. Krabbe, ; Lamers, L. M. ; McDonnell, J. ; J. J. V. Busschbach, .
    In: Health Economics.
    RePEc:wly:hlthec:v:15:y:2006:i:10:p:1121-1132.

    Full description at Econpapers || Download paper

  40. A comparison of individual and social time trade-off values for health states in the general population. (2006). Johannesson, Magnus ; Burstrom, Kristina ; Diderichsen, Finn.
    In: Health Policy.
    RePEc:eee:hepoli:v:76:y:2006:i:3:p:359-370.

    Full description at Econpapers || Download paper

  41. Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data. (2005). Beale, Sophie ; Bagust, Adrian.
    In: Health Economics.
    RePEc:wly:hlthec:v:14:y:2005:i:3:p:217-230.

    Full description at Econpapers || Download paper

  42. Current state of the art in preference-based measures of health and avenues for further research. (2005). Brazier, John.
    In: MPRA Paper.
    RePEc:pra:mprapa:29762.

    Full description at Econpapers || Download paper

  43. Measuring Changes in Health Capital. (2005). Labeaga, Jose ; Oliver, Xisco ; Spadaro, Amedeo.
    In: Working Papers.
    RePEc:fda:fdaddt:2005-15.

    Full description at Econpapers || Download paper

  44. A comparison of the EQ‐5D and SF‐6D across seven patient groups. (2004). Tsuchiya, Aki ; Roberts, Jennifer ; Brazier, John ; Busschbach, Jan.
    In: Health Economics.
    RePEc:wly:hlthec:v:13:y:2004:i:9:p:873-884.

    Full description at Econpapers || Download paper

  45. A single European currency for EQ-5D health states. (2003). Tsuchiya, Aki ; Parkin, David ; Greiner, Wolfgang ; Sintonen, Harri ; Weijnen, Tom ; Charro, Frank ; Oppe, Siem ; Ohinmaa, Arto ; Krabbe, Paul ; Kind, Paul ; Dolan, Paul ; Roset, Montserat ; Nieuwenhuizen, Martin ; Buxton, Martin ; Badia, Xavier ; Busschbach, Jan.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:4:y:2003:i:3:p:222-231.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-09-20 20:22:15 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated August, 3 2024. Contact: Jose Manuel Barrueco.